User:Ann Taylor/GLP-1 agonists: Difference between revisions
Jump to navigation
Jump to search
Ann Taylor (talk | contribs) No edit summary |
Ann Taylor (talk | contribs) No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==GLP-1 agonists== | ==GLP-1 agonists== | ||
<StructureSection load=' | <StructureSection load='5NX2' size='340' side='right' caption='GLP-1 bound to receptor complex'> | ||
<scene name='10/1043704/Glp-1_peptide/1'>Glucagon-like peptide agonists</scene> (GLP) are used to treat type 2 diabetes and obesity <ref>PMID:38639549</ref>. They GLP-1 agonists bind to the GLP receptor. | <scene name='10/1043704/Glp-1_peptide/1'>Glucagon-like peptide agonists</scene> (GLP) are used to treat type 2 diabetes and obesity <ref>PMID:38639549</ref>. They GLP-1 agonists bind to the GLP receptor. | ||
The GLP receptor is a G-protein coupled receptor. Its secondary structure is highlighted in <scene name='10/1043704/Glpr_secondary/1'>this view</scene>. The hydrophobic residues are shown in grey and the polar residues are shown in magenta in <scene name='10/1043704/Glpr_hydrophobic_hydrophilic/1'>this view</scene>. | |||
</StructureSection> | </StructureSection> | ||